Take a look at some of Monday's morning movers:
Citigroup - The bank reported second-quarter profit of $1 per share , above estimates of $0.89. Separately, CEO Vikram Pandit told the U.K.’s Sunday Telegraph that the bank may seek permission soon to hike its dividend for the first time since the 2008 financial crisis. Pandit said he believes there will be sufficient capital to make such a move by year’s end.
Par Pharmaceutical- The drugmaker will be acquired by private-equity firm
TPGfor $50 a share, or $1.9 billion cash. That compares to Par's Friday close of $36.58.
Procter & Gamble - Bloomberg is reporting that the company is assessing possible interest in its Duracell battery and Iams pet food units. Analysts say the two units could bring in a total of $7 billion if sold.
GlaxoSmithKline - The drugmaker is expected to announce a deal this morning to acquire Human Genome Sciences for about $2.8 billion, ending a three-month effort by Glaxo. The deal amounts to about $14 per share, up from the previous $13 per share offer.
Apollo Global Management - Apollo is said to be considering a bid for McGraw-Hill’s education unit, according to The Wall Street Journal. Analysts say the unit could bring in as much as $3.8 billion in a sale.
Page 1 of 3 | Next Page
PG News & Analysis